Healthcare & Life Sciences

EyeSense GmbH

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

EyeSense GmbH develops FiberSense, a CE-marked continuous glucose monitoring system that uses optical fiber sensor technology to measure glucose levels in interstitial fluid for diabetes management at home.

Explore EyeSense GmbH's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.